Qiagen (QGEN) Meets Q4 Earnings Estimates

分组1 - Qiagen reported quarterly earnings of $0.62 per share, matching the Zacks Consensus Estimate, and showing a slight decrease from $0.64 per share a year ago, with an earnings surprise of +0.83% [1] - The company achieved revenues of $540.42 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 2.36%, and up from $521.2 million year-over-year [2] - Qiagen has surpassed consensus EPS estimates three times and revenue estimates four times over the last four quarters [2] 分组2 - The stock has increased approximately 9.6% since the beginning of the year, outperforming the S&P 500, which gained 1.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.61 on revenues of $512.6 million, and for the current fiscal year, it is $2.61 on revenues of $2.21 billion [7] - The Medical - Biomedical and Genetics industry, to which Qiagen belongs, is currently ranked in the top 37% of over 250 Zacks industries, indicating a favorable outlook [8]